Share This Article:

Recovery of nigrostriatal dopaminergic system insufficiency by allotransplantation of embryonic brain tissue

Abstract Full-Text HTML XML Download Download as PDF (Size:307KB) PP. 240-245
DOI: 10.4236/wjns.2013.34032    3,461 Downloads   5,121 Views  

ABSTRACT

In an experiment in rats with electrolytic lesion of the compact part of substantia nigra (SN) and after allotransplantation of the embryonic tissue of SN in the caudate nucleus the features of movement and emotional behavior in the Open Field Test (OFT), the rotation movements caused by an administration of amphetamine, a content of catecholamines in the caudate nucleus, hypothalamus and blood plasma have been investigated. It is shown that the electrolytic lesion causes violations of the statokinetic reflexes, the horizontal and the vertical movement activity, enhances the rotatory behavior, slow the orienttate-searching and the emotional reactions that combined with disbalance in dopamine-and noradrenalinetransmitter systems functioning. Allotransplantation of the embryonic dofaminsynthesizing brain tissue contributes to the restoration of movement activeity and its specific neurotransmitter ensuring. 

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Berchenko, O. and Usmentseva, Y. (2013) Recovery of nigrostriatal dopaminergic system insufficiency by allotransplantation of embryonic brain tissue. World Journal of Neuroscience, 3, 240-245. doi: 10.4236/wjns.2013.34032.

References

[1] Maries, E. and Kordower, J.H. (2002) Etiology of Parkinson’s disease: Genetics and environment revisited. Proceedings of the National Academy of Sciences, 99, 13972-13974. http://dx.doi.org/10.1073/pnas.242594999
[2] Slominsky, P.A., Miloserdova, O.V. and Popov, S. (2003) Analysis of deletions’ mutations in PARK2 gene with idiopathic Parkinson’s disease form. Genetics, 2, 223-228. (in Russian)
[3] McGeer, P.L., McGeer, E.G. and Suzuki, J.S. (1977) Aging and extrapyramidal function. Archives of Neurology, 34, 33-35. http://dx.doi.org/10.1001/archneur.1977.00500130053010
[4] Karaban, I.N. (2006) Medicines of levodopa it the pathogenesis therapy of Parkinson’s disease. International Neurological Journal, 6, 16-20. (in Russian)
[5] Jellinger, K.A. (1991) Pathology of Parkinson’s disease. Changes other than the nigrostriatal pathway. Molecular and Chemical Neuropathology, 14, 153-197. http://dx.doi.org/10.1007/BF03159935
[6] Hoogendijk, W.J., Pool, C.W., Troost, D., et al. (1995) Image analyser-assisted morphometry of the locus coeruleus in Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Brain, 118, 131-143. http://dx.doi.org/10.1093/brain/118.1.131
[7] Halliday, G.M., Blumbergs, P.C., Cotton, R.G., et al. (1990) Loss of brainstem serotonin-and substance P-containing neurons in Parkinson’s disease. Brain Research, 510, 104-107. http://dx.doi.org/10.1016/0006-8993(90)90733-R
[8] Bjorklund, A. and Gage, F.H. (1985) Neural grafting in animal models of neurodegenerative diseases. Annals of the New York Academy of Sciences, 457, 53-81. http://dx.doi.org/10.1111/j.1749-6632.1985.tb20799.x
[9] Chekhonin, V.P., Belopasov, V.V., Dmitrieva, T.B. and Baklaushev, V.P. (1999) Transplantation of embryonic nervous tissue in therapy of parkinsonism: A current state of a problem. Journal of Neurology and Psychiatry, 11, 60-66. (in Russian)
[10] Ugriumov, M.V. (2001) Experimental and clinical neurotransplantation—A current status and prospects. Science of Longevity, 1, 9-17. (in Russian)
[11] Clarke, C.E. (2004) Neuroprotection and pharmacotherapy for motor symptoms in Parkinson’s disease. The Lancet Neurology, 8, 466-474. http://dx.doi.org/10.1016/S1474-4422(04)00823-3
[12] Kordower, J.H., Freeman, T.B., Snow, B.J., et al. (1995) Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson’s disease. The New England Journal of Medicine, 332, 1118-1124. http://dx.doi.org/10.1056/NEJM199504273321702
[13] Lund, R.D. and Hauschka, S.D. (1976) Transplanted neural tissue develops connections with host rat brain. Science, 4253, 582-584. http://dx.doi.org/10.1126/science.959815
[14] Dunnett, S.B., Ryan, C.N., Levin, P.D., et al. (1987) Functional consequences of embryonic neocortex transplanted to rats with prefrontal cortex lesions. Behavioral Neuroscience, 101, 489-503. http://dx.doi.org/10.1037/0735-7044.101.4.489
[15] Nikkhah, G., Cunningham, M.G., McKay, R. and Bjorklund, A. (1995) Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. II. Transplant-induced behavioral recovery. The Journal of Neuroscience, 15, 3562-3570.
[16] Nieto-Sampedro, M., Lewis, E.R., Cotman, C.W., et al. (1982) Brain injury causes a time-dependent increase in neuronotrophic activity at the lesion site. Science, 4562, 860-861. http://dx.doi.org/10.1126/science.7100931
[17] Chekhonin, V.P., Lebedev, S.V., Volkov, A.V., Pavlov, K.A., et al. (2010) Activation of expression of brainderived neurotrophic factor in the zone of implantation of allogeneic and xenogeneic stem (progenitor) cells of nerve tissue in rats with cerebral ischemic stroke. Cell Technologies in Biology and Medicine, 4, 195-198. (in Russian)
[18] Giacobini, M.M. (1993) Growth factors and the developing central nervous system: In vivo studies utilizing intraocular brain tissue transplantation with special reference to differential trophic effects of the IGF, FGF and PDGF families.
[19] Berchenko, O.G. and Titkova, A.M. (1998) Neurobiological effects features of neurotransplantation and distant implantation of embryonic tissue of substantia nigra in modeling extrapyramidal pathology. Physiologycal Journal, 44, 17. (in Ukrainian)
[20] Bures, J., Petran, M. and Zachar, J. (1967). Electrophysiological methods in biological research. Izdatel’stvo Inostrannoi Literatury, Moscow. (in Russian)
[21] Hall, C.S. (1936) Emotional behavior in the rat. III. The relationship between emotionality and ambulatory activity. Journal of Comparative Psychology, 22, 345-352. http://dx.doi.org/10.1037/h0059253
[22] Bures, J., Bureshova, O. and Houston, P.D. (1991) Techniques and basic experiments for the study of brain and behavior. Vysshaya Shkola, Moscow. (in Russian)
[23] Henning, J., Strauss, U., Wree, A., et al. (2008) Differential astroglial activation in 6-hydroxydopamine models of Parkinson’s disease. Neuroscience Research, 62, 246-253. http://dx.doi.org/10.1016/j.neures.2008.09.001
[24] Hirsch, E.C., Hunot, S. and Hartmann, A. (2005) Neuro-inflammatory processes in Parkinson’s disease. Parkinsonism & Related Disorders, 11, 9-15. http://dx.doi.org/10.1016/j.parkreldis.2004.10.013
[25] Yang, J., Sadler, T.R., Givrad, T.K., et al. (2007) Changes in brain functional activation during resting and locomotor states after unilateral nigrostriatal damage in rats. Neuroimage, 36, 755-773. http://dx.doi.org/10.1016/j.neuroimage.2007.03.010
[26] Dovedova, E.L. (2008) Activity of the brain dopaminergic system with injection of exogenous DOPA. Korsakov Journal of Neurology and Psychiatry, 9, 73-75. (in Russian)

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.